Detalles de la búsqueda
1.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453781
2.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37387213
3.
Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer.
Br J Cancer
; 129(9): 1516-1523, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697030
4.
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
Oncologist
; 28(10): e867-e876, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589218
5.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988749
6.
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.
J Natl Compr Canc Netw
; 21(1): 33-41.e16, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634607
7.
Antibody-Drug Conjugate Revolution in Breast Cancer: The Road Ahead.
Curr Treat Options Oncol
; 24(5): 442-465, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966267
8.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183733
9.
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
Cancer
; 128(19): 3552-3563, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35913436
10.
Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors.
J Natl Compr Canc Netw
; 20(13)2022 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130491
11.
Informing the development of multidisciplinary interventions to help breast cancer patients return to work: a qualitative study.
Support Care Cancer
; 30(10): 8287-8299, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819520
12.
Unhealthy behaviors after breast cancer: Capitalizing on a teachable moment to promote lifestyle improvements.
Cancer
; 127(15): 2774-2787, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887074
13.
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Br J Cancer
; 125(11): 1486-1493, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34588616
14.
Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up.
Breast Cancer Res Treat
; 188(2): 501-509, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891298
15.
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.
Breast Cancer Res Treat
; 190(3): 517-529, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559354
16.
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Lancet Oncol
; 20(10): 1360-1369, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31494037
17.
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
Int J Cancer
; 145(12): 3359-3369, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087564
18.
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.
PLoS Med
; 16(12): e1002989, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869400
19.
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.
Breast Cancer Res Treat
; 173(3): 573-583, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368744
20.
Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer.
Cancer Invest
; 37(1): 29-38, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656969